Kirsten E. Peters, Wendy A. Davis, Jun Ito, Kaye Winfield, Thomas Stoll, Scott D. Bringans, Richard J. Lipscombe and Timothy M.E. Davis. Diabetes Care.
Conclusions
The current study has identified novel plasma biomarkers (apoA4, CD5L, C1QB, and IBP3) that may improve the prediction of rapid decline in renal function independently of recognized clinical risk factors in type 2 diabetes.